These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7985663)

  • 1. Role of bioincompatibility in dialysis morbidity and mortality.
    Lazarus JM; Owen WF
    Am J Kidney Dis; 1994 Dec; 24(6):1019-32. PubMed ID: 7985663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatible characteristics of high-performance membranes.
    Uda S; Mizobuchi M; Akizawa T
    Contrib Nephrol; 2011; 173():23-29. PubMed ID: 21865772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility of dialysis membrane.
    Kes P
    Acta Med Croatica; 1999; 53(1):29-40. PubMed ID: 10437275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical sequelae of complement activation in hemodialysis.
    Hakim RM
    Clin Nephrol; 1986; 26 Suppl 1():S9-12. PubMed ID: 3829474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility of dialysis membranes: effects of chronic complement activation.
    Hakim RM; Fearon DT; Lazarus JM
    Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatibility of PMMA membranes in acute and chronic patients with renal failure.
    Manzoni C; Locatelli F
    Contrib Nephrol; 1999; 125():65-75. PubMed ID: 9895431
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adhesion molecules in patients with chronic renal failure treated with haemodialysis].
    Musiał K; Zwolińska D
    Pol Merkur Lekarski; 2002 Sep; 13(75):177-81. PubMed ID: 12474564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of cytokine production in hemodialysis.
    Pertosa G; Grandaliano G; Gesualdo L; Schena FP
    Kidney Int Suppl; 2000 Aug; 76():S104-11. PubMed ID: 10936806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the dialysis membrane on outcome of ESRD patients.
    Hakim RM
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S71-5. PubMed ID: 9892369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
    Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
    Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
    [No Abstract]   [Full Text] [Related]  

  • 11. Biocompatibility: is it a relevant consideration for today's haemodialysis?
    Shaldon S; Vienken J
    Int J Artif Organs; 1996 Apr; 19(4):201-14. PubMed ID: 8786170
    [No Abstract]   [Full Text] [Related]  

  • 12. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines and bioincompatibility.
    Gesualdo L; Pertosa G; Grandaliano G; Schena FP
    Nephrol Dial Transplant; 1998 Jul; 13(7):1622-6. PubMed ID: 9681699
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical impact of biocompatible dialysis membranes on patient morbidity and mortality: an appraisal of the evidence.
    Churchill DN
    Nephrol Dial Transplant; 1995; 10 Suppl 10():52-6. PubMed ID: 8825434
    [No Abstract]   [Full Text] [Related]  

  • 15. Dissociation between complement activation, integrin expression and neutropenia during hemodialysis.
    Rousseau Y; Carreno MP; Poignet JL; Kazatchkine MD; Haeffner-Cavaillon N
    Biomaterials; 1999 Oct; 20(20):1959-67. PubMed ID: 10514074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of complement activation, cytokine liberation and beta 2 microglobulin in the use of various dialysis and hemofiltration membranes].
    Falkenhagen D; Thomaneck U; Brown GS; Werner H; Klinkmann H
    Z Urol Nephrol; 1989 Oct; 82(10):541-50. PubMed ID: 2692346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis membrane biocompatibility: effects on cellular elements.
    Coli L; De Sanctis LB; Feliciangeli G; Iannelli S; Scolari MP; Todeschini P; Tumietto F; Costigliola P; Chiodo F
    Nephrol Dial Transplant; 1995; 10 Suppl 10():27-32. PubMed ID: 8825429
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunomodulation and biomaterials.
    Tetta C; Camussi G; Mariano F; Triolo G; Vercellone A
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(2):253-63. PubMed ID: 8318617
    [No Abstract]   [Full Text] [Related]  

  • 19. The link of biocompatibility to cytokine production.
    Panichi V; Migliori M; De Pietro S; Taccola D; Andreini B; Metelli MR; Giovannini L; Palla R
    Kidney Int Suppl; 2000 Aug; 76():S96-103. PubMed ID: 10936805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citrate anticoagulation does not correct cuprophane bioincompatibility as evaluated by the expression of leukocyte surface molecules.
    Dhondt A; Vanholder R; Waterloos MA; Glorieux G; De Smet R; Lameire N
    Nephrol Dial Transplant; 1998 Jul; 13(7):1752-8. PubMed ID: 9681723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.